Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FAPI-74 PET/CT in Gastric or Esophageal Cancer
NCT07217704Phase 3Recruiting
- Sponsor
- SOFIE
- Start
- Nov 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of [18F]-FAPI-74 in gastric cancer (GC), esophageal cancer, gastroesophageal junction cancer, sponsored by SOFIE. Started Nov 2025; status: recruiting.
02
Drugs
[18F]-FAPI-74
03
Conditions
gastric cancer (GC)esophageal cancergastroesophageal junction cancer
Beyond the preview
Go deeper on NCT07217704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07217704.